We are live on ! Find out more
GCM

Galibier Capital Management Portfolio holdings

AUM $300M
1-Year Est. Return 22.03%
This Fund
S&P 500
This Quarter Est. Return
+1.95%
1 Year Est. Return
+22.03%
3 Year Est. Return
+66.83%
5 Year Est. Return
+107.72%
10 Year Est. Return
AUM
$220M
AUM Growth
+$52.1M
Cap. Flow
+$47.9M
Cap. Flow %
21.82%
Top 10 Hldgs %
77.75%
Holding
34
New
3
Increased
17
Reduced
5
Closed
3

Top Buys

Rank Stock Value
1
NTR icon
Nutrien
NTR
+$23.7M
2
EMR icon
Emerson Electric
EMR
+$12.3M
3
MDT icon
Medtronic
MDT
+$10.4M
4
ENB icon
Enbridge
ENB
+$3.59M
5
MFC icon
Manulife Financial
MFC
+$3.05M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$6.89M
2
WBC
WABCO HOLDINGS INC.
WBC
+$1.75M
3
MRK icon
Merck
MRK
+$1.4M
4
OSK icon
Oshkosh
OSK
+$833K
5
MIDD icon
Middleby
MIDD
+$672K

Sector Composition

Rank Sector Weight
1 Financials 33.21%
2 Energy 16.07%
3 Industrials 14.58%
4 Healthcare 14.28%
5 Materials 11.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TFC icon
26
Truist Financial
TFC
$63.3B
$1.75M 0.8%
35,593
+241
+0.7% +$11.8K
AIG icon
27
American International
AIG
$41.7B
$1.71M 0.78%
32,121
-4,845
-13% -$241K
CL icon
28
Colgate-Palmolive
CL
$73.1B
$1.64M 0.75%
22,908
-6,954
-23% -$494K
VOYA icon
29
Voya Financial
VOYA
$9.01B
$1.62M 0.74%
29,233
+5,233
+22% +$280K
TMO icon
30
Thermo Fisher Scientific
TMO
$213B
$759K 0.35%
2,585
GOOGL icon
31
Alphabet (Google) Class A
GOOGL
$4.36T
$415K 0.19%
7,660
BIIB icon
32
Biogen
BIIB
$30B
-29,167
Closed -$6.89M
MRK icon
33
Merck
MRK
$322B
-17,678
Closed -$1.4M
WBC
34
DELISTED
WABCO HOLDINGS INC.
WBC
-13,266
Closed -$1.75M

Similar funds

Galibier Capital Management's Q2 2019 Portfolio in Review

As of Q2 2019, Galibier Capital Management held 34 positions worth $220M, up 31% from $168M the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Galibier Capital Management deployed $47.9M of net new capital in Q2 2019, opening 3 new positions and adding to 17 existing holdings. Its largest new stake was Nutrien: 454,391 shares worth $24.4M.

By sector, the portfolio is most concentrated in Financials at 33% of assets, down from 40% a quarter earlier, followed by Energy and Industrials.

On the sell side, the largest reduction was Oshkosh, an estimated $833K trimmed.

  • Galibier Capital Management's largest Q2 2019 buy was Nutrien: 454,391 shares worth $24.4M.
  • Galibier Capital Management added most to Emerson Electric in Q2 2019, an estimated $12.3M increase.
  • Galibier Capital Management's biggest Q2 2019 reduction was Oshkosh, cutting an estimated $833K.
  • Galibier Capital Management fully exited Biogen in Q2 2019, selling an estimated $6.89M.
  • Galibier Capital Management's ten largest holdings make up 78% of its $220M portfolio in Q2 2019.
  • Galibier Capital Management opened 3 new positions and closed 3 in Q2 2019.
  • Galibier Capital Management's portfolio value rose 31% quarter-over-quarter to $220M.

Based on Galibier Capital Management's 13F filing for Q2 2019, filed 2 Aug 2019.